What changes occur in immune-related markers during combination therapy?
Partial inflammation and coagulation-related indicators decreased faster after adding Thymalin.[1] ↗
Research on adjuvant therapy in COVID-19 patients and cellular mechanisms
Study design and co-treatment limitations; thymus extract mixtures are not equivalent to clearly sequenced single peptides.
View the Article Title and Full Citation+
Results and Prospects of Using Activator of Hematopoietic Stem Cell Differentiation in Complex Therapy for Patients with COVID-19.
Stem Cell Reviews and Reports · Volume Issue Year 2021
First published 2021-02-11 · PMID 33575961
DOI 10.1007/s12015-020-10087-6







